Status:
COMPLETED
Rural MOUD Telemedicine in Primary Care Phase 1
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-use Disorder
Eligibility:
All Genders
18-80 years
Brief Summary
The feasibility study (Phase 1) will examine the implementation of telemedicine (TM) in six rural clinics in two states/regions with varying levels of OBOT capacity.
Detailed Description
The dramatic increases in opioid overdose deaths across the nation, particularly in rural areas, call for a rapid expansion of access to medication treatment for opioid use disorder (MOUD).There is a ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Aged 18-80 years old, inclusive, at the time of the qualifying visit
- with OUD diagnosis
- At least 1 visit to the participating clinics from 9 months before and 6 months after the date of intervention implementation
Exclusion
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 5 2021
Estimated Enrollment :
36762 Patients enrolled
Trial Details
Trial ID
NCT04418453
Start Date
June 1 2020
End Date
November 5 2021
Last Update
May 11 2023
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Mary's Hospital and Clinics
Cottonwood, Idaho, United States, 83522
2
Syringa Hospital and Clinics
Grangeville, Idaho, United States, 83530
3
Penobscot Community Health Care
Belfast, Maine, United States, 04915
4
Hometown Health Center
Dexter, Maine, United States, 04930